The estimated incidence of idiosyncratic drug-induced liver injury (DILI) in the general
population is 13.9 to 19.1 per 100,000 patients per year. Age itself is not a risk factor, but …

Drug-induced liver injury (DILI) is a common health disorder that is unpredictable and often
poorly understood in pathogenesis. DILI may result in serious, sometimes fatal liver injury in …

Aim: The average age of Japanese patients with drug‐induced liver injury (DILI) is expected
to rise as the population ages. The aim of this study was to evaluate the clinical …

Purpose: Idiosyncratic drug induced liver injury (DILI) is a rare but serious liver disorder. It is
known to occur in the elderly but the causative agents, clinical characteristics, and outcomes …

Drug-induced liver injury (DILI) is a rare, unpredictable, and potentially serious adverse
reaction. It is induced by many drugs, herbs, and dietary supplements and represents a …

Abstract Purpose of Review With its high variability in both presentation and severity, drug-
induced liver injury (DILI) is a complex condition increasingly confronting all providers. DILI …

Background: Discontinuation of the causative DILI agent generally leads to liver damage
resolution, except in cases evolving to fulminant hepatic failure or chronicity. We previously …

Older patients with hepatotoxicity have been scarcely studied in idiosyncratic drug‐induced
liver injury (DILI) cohorts. We sought the distinctive characteristics of DILI in older patients …

The elderly demographic is the fastest-growing segment of the world's population and is
projected to exceed 1.5 billion people by 2050. With multimorbidity, polypharmacy …

Drug-induced liver injury (DILI) is an important cause of hospitalisation and of medication
deregistration. In old age, susceptibility to DILI is affected by changes in physiology and …